ClinicalTrials.Veeva

Menu

Paricipant Preferences in the Treatment of Inflammatory Bowel Disease (IBD) in Europe

Takeda logo

Takeda

Status

Completed

Conditions

Colitis, Ulcerative
Inflammatory Bowel Diseases
Crohn Disease

Study type

Observational

Funder types

Industry

Identifiers

NCT04597905
U1111-1259-3241 (Registry Identifier)
IBD-5013

Details and patient eligibility

About

The purpose of this survey is to describe Crohn's disease (CD) participants' as well as ulcerative colitis (UC) participants' preferences towards the attributes of treatment with advanced therapies for IBD, including safety and efficacy profiles, frequency and route of administration (RoA) in a real-world setting.

Full description

This is a descriptive, observational, cross-sectional survey of participants with IBD. The survey will look into the preferences of participants towards the attributes of treatment with advanced therapies for IBD based on DCE (experimentally designed survey), including safety and efficacy profiles, frequency and RoA in a real-world setting, in European participants living with CD or UC.

The survey will involve data collection in a real-world setting via an online self-reported questionnaire hosted on the Carenity platform, an international participant community.

The survey will enroll approximately 600 participants. Participants will be enrolled in two observational cohorts:

  • CD Participants
  • UC Participants

This multi-center trial will be conducted in France, the United Kingdom, Italy, Spain, Belgium, Switzerland, the Netherlands.

Enrollment

686 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Self-reported suffering from CD or UC.

Exclusion criteria

  1. Have never been ever treated with prescription medications for CD or UC.
  • Should be included in the study only once.
  • Data collected from participants who subsequently withdraw their consent will not be included in or will be deleted from the database.

Trial design

686 participants in 2 patient groups

CD Participants
Description:
Participants diagnosed with CD from the 7 participating countries will take part in survey to collect data regarding their preferences towards the attributes of treatments based on DCE survey with advanced therapies for IBD, including safety and efficacy profiles, frequency and RoA in a real-world setting and data collection will be conducted in a real-world setting via an online self-reported questionnaire hosted on the Carenity platform, an international patient community.
UC Participants
Description:
Participants diagnosed with UC from the 7 participating countries will take part in survey to collect data regarding theirpreferences towards the attributes of treatments based on DCE survey with advanced therapies for IBD, including safety and efficacy profiles, frequency and RoA in a real-world setting and data collection will be conducted in a real-world setting via an online self-reported questionnaire hosted on the Carenity platform, an international patient community.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems